enVVeno Medical (NVNO) Gross Profit (2017 - 2019)

enVVeno Medical (NVNO) posted quarterly Gross Profit of $31243.0 for Q1 2019, up 2.56% quarter-over-quarter from $30462.0 in Q4 2018.

enVVeno Medical (NVNO) Gross Profit (2017 - 2019) Analysis & Trends

enVVeno Medical's Gross Profit history runs 3 years deep, the most recent figure standing at $31243.0 for Q1 2019.

In Q1 2019, Gross Profit changed N/A year-over-year to $31243.0; the TTM figure through Mar 2019 stood at $186730.0 (changed N/A YoY), while the FY2018 annual figure was $186552.0, up 7508.16% from the prior year.
Gross Profit for Q1 2019 stood at $31243.0, up from $30462.0 in the prior quarter.
The five-year high for Gross Profit was $83363.0 in Q2 2018, with the low at -$105061.0 in Q3 2017.
The 3-year median for Gross Profit is $38800.0 (2017), against an average of $28229.7.
Peak annual rise in Gross Profit reached 139.66% in 2018, while the deepest fall reached 60.51% in 2018.
enVVeno Medical's Gross Profit stood at $77139.0 in 2017, then sank by 60.51% to $30462.0 in 2018, then grew by 2.56% to $31243.0 in 2019.
Business Quant data shows NVNO's Gross Profit at $31243.0 in Q1 2019, $30462.0 in Q4 2018, and $41662.0 in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.95 Bn	193.35 Bn	7.27 Bn
2	Stryker	128.10 Bn	124.63 Bn	4.50 Bn
3	Medtronic	118.91 Bn	109.69 Bn	6.41 Bn
4	Boston Scientific	73.43 Bn	72.89 Bn	3.85 Bn
5	Edwards Lifesciences	51.91 Bn	47.66 Bn	1.35 Bn
6	Dexcom	34.52 Bn	32.58 Bn	830.00 Mn
7	GE HealthCare Technologies	33.94 Bn	31.83 Bn	2.18 Bn
8	Koninklijke Philips	26.37 Bn	23.05 Bn	4.55 Bn
9	Steris	23.14 Bn	22.66 Bn	684.20 Mn
10	enVVeno Medical	7.12 Mn	7.12 Mn	-

Download Data